Name: in vitro differentiation of human cd4+foxp3+ induced regulatory t cells (itregs) from na&#239;ve cd4+ t cells using a tgf-&#946;-containing protocol
Uploaded: 2016-12-30T14:00:00
Description: Watch this Scientific Journal Video about In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells iTregs from NaÃƒÂ¯ve CD4+ T Cells Using a TGF-ÃŽÂ²-containing Protocol at JoVE.com

Nina Nagel is gratefully acknowledged for technical assistance during the video shoot and experimental preparation. We thank Eva-Maria Weiss for help with the intracellular FOXP3 staining protocol and Elisabeth Suri-Payer and Nina Oberle for establishing the nTreg isolation protocol. Matilda Eriksson and Peri Noori are acknowledged for laboratory management. 
Funding: A.S. was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme, the Dr. &#197;ke Olsson Foundation and KI research foundations; A.S. and J.T. were supported by a CERIC (Center of Excellence for Research on Inflammation and Cardiovascular disease) grant, J.T. was supported by Vetenskapsr&#229;det Medicine and Health (Dnr 2011-3264), Torsten S&#246;derberg Foundation, FP7 STATegra, AFA Insurance and Stockholm County Council.

人外周血单核细胞（PBMC）中新鲜从卡罗林斯卡大学医院，瑞典购买匿名健康供体的血沉棕黄层分离。从区域伦理审查委员会在斯德哥尔摩（Regionalaetikprövningsnämnden我斯德哥尔摩），得到了该实验的伦理许可证，瑞典（批准文号：2013/1458年至1431年/ 1）。 从外周血1. T细胞分离<ol><li> PBMC隔离 <ol><li>预先铺设15毫升密度离心培养基在50ml管（每血沉棕黄层5管）（如聚蔗糖）溶液中。?...

<ol>
	<li>Sakaguchi, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulatory+T+cells:+history+and+perspective.">Regulatory T cells: history and perspective.</a> Methods Mol.Biol. 707, 3-17 (2011).</li><li>DeLeeuw, R. J., Kost, S. E., Kakal, J. A., Nelson, B. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+prognostic+value+of+FoxP3++tumor-infiltrating+lymphocytes+in+cancer:+A+critical+review+of+the+literature.">The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: A critical review of the literature.</a> Clin Can Res. 18 (11), 3022-3029 (2012).</li><li>Liu, C., Workman, C. J., Vignali, D. A. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeting+Regulatory+T+Cells+in+Tumors.">Targeting Regulatory T Cells in Tumors.</a> FEBS J. , (2016).</li><li>Trzonkowski, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=First-in-man+clinical+results+of+the+treatment+of+patients+with+graft+versus+host+disease+with+human+ex+vivo+expanded+CD4+CD25+C.">First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+C.</a> Clin. Immunol. 133, 22-26 (2009).</li><li>Brunstein, C. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Infusion+of+ex+vivo+expanded+T+regulatory+cells+in+adults+transplanted+with+umbilical+cord+blood:+safety+profile+and+detection+kinetics.">Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.</a> Blood. 117, 1061-1070 (2011).</li><li>Di Ianni, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tregs+prevent+GVHD+and+promote+immune+reconstitution+in+HLA-haploidentical+transplantation.">Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.</a> Blood. 117, 3921-3928 (2011).</li><li>Edinger, M., Hoffmann, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulatory+T+cells+in+stem+cell+transplantation:+strategies+and+first+clinical+experiences.">Regulatory T cells in stem cell transplantation: strategies and first clinical experiences.</a> Curr. Opin. Immunol. 23, 679-684 (2011).</li><li>Bluestone, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Type+1+diabetes+immunotherapy+using+polyclonal+regulatory+T+cells.">Type 1 diabetes immunotherapy using polyclonal regulatory T cells.</a> Science Transl Med. 7 (315), 189 (2015).</li><li>Haribhai, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+central+role+for+induced+regulatory+T+cells+in+tolerance+induction+in+experimental+colitis.">A central role for induced regulatory T cells in tolerance induction in experimental colitis.</a> J. Immunol. 182, 3461-3468 (2009).</li><li>Haribhai, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+requisite+role+for+induced+regulatory+T+cells+in+tolerance+based+on+expanding+antigen+receptor+diversity.">A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity.</a> Immunity. 35, 109-122 (2011).</li><li>Abbas, A. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regulatory+T+cells:+recommendations+to+simplify+the+nomenclature.">Regulatory T cells: recommendations to simplify the nomenclature.</a> Nat.Immunol. 14, 307-308 (2013).</li><li>Curotto de Lafaille, M. A., Lafaille, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Natural+and+adaptive+foxp3++regulatory+T+cells:+more+of+the+same+or+a+division+of+labor.">Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor.</a> Immunity. 30, 626-635 (2009).</li><li>Huehn, J., Polansky, J. K., Hamann, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epigenetic+control+of+FOXP3+expression:+the+key+to+a+stable+regulatory+T-cell+lineage.">Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage.</a> Nat. Rev. Immunol. 9, 83-89 (2009).</li><li>Schmitt, E. G., Williams, C. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+and+function+of+induced+regulatory+T+cells.">Generation and function of induced regulatory T cells.</a> Front Immunol. 4, 152 (2013).</li><li>Pillai, V., Ortega, S. B., Wang, C. K., Karandikar, N. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transient+regulatory+T-cells:+a+state+attained+by+all+activated+human+T-cells.">Transient regulatory T-cells: a state attained by all activated human T-cells.</a> Clin.Immunol. 123, 18-29 (2007).</li><li>Wang, J., Ioan-Facsinay, A., vander Voort, E. I. H., Huizinga, T. W., Toes, R. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transient+expression+of+FOXP3+in+human+activated+nonregulatory+CD4++T+cells.">Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.</a> Eur. J. Immunol. 37, 129-138 (2007).</li><li>Josefowicz, S. Z., Rudensky, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Control+of+regulatory+T+cell+lineage+commitment+and+maintenance.">Control of regulatory T cell lineage commitment and maintenance.</a> Immunity. 30, 616-625 (2009).</li><li>Sun, C. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Small+intestine+lamina+propria+dendritic+cells+promote+de+novo+generation+of+Foxp3+T+reg+cells+via+retinoic+acid.">Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.</a> J.Exp.Med. 204, 1775-1785 (2007).</li><li>Coombes, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+functionally+specialized+population+of+mucosal+CD103++DCs+induces+Foxp3++regulatory+T+cells+via+a+TGF-beta+and+retinoic+acid-dependent+mechanism.">A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.</a> J. Exp. Med. 204, 1757-1764 (2007).</li><li>Kang, S. G., Lim, H. W., Andrisani, O. M., Broxmeyer, H. E., Kim, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Vitamin+A+metabolites+induce+gut-homing+FoxP3++regulatory+T+cells.">Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells.</a> J. Immunol. 179, 3724-3733 (2007).</li><li>Mucida, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Retinoic+acid+can+directly+promote+TGF-beta-mediated+Foxp3(+)+Treg+cell+conversion+of+naive+T+cells.">Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells.</a> Immunity. 30, 471-472 (2009).</li><li>Schmidt, A., Eriksson, M., Shang, M. -. M., Weyd, H., Tegn&#233;r, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparative+Analysis+of+Protocols+to+Induce+Human+CD4+Foxp3++Regulatory+T+Cells+by+Combinations+of+IL-2,+TGF-beta,+Retinoic+Acid,+Rapamycin+and+Butyrate.">Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.</a> PloS one. 11 (2), 0148474 (2016).</li><li>Furusawa, Y., Obata, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=regulatory+T+cells.">regulatory T cells.</a> Nature. 504, 446-450 (2013).</li><li>Arpaia, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Metabolites+produced+by+commensal+bacteria+promote+peripheral+regulatory+T-cell+generation.">Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.</a> Nature. 504, 451-455 (2013).</li><li>Battaglia, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapamycin+promotes+expansion+of+functional+CD4+CD25+FOXP3++regulatory+T+cells+of+both+healthy+subjects+and+type+1+diabetic+patients.">Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients.</a> J. Immunol. 177, 8338-8347 (2006).</li><li>Hippen, K. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Massive+ex+vivo+expansion+of+human+natural+regulatory+T+cells+(T(regs))+with+minimal+loss+of+in+vivo+functional+activity.">Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.</a> Sci. Transl. Med. 3, 41 (2011).</li><li>Schmidt, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+macrophages+induce+CD4(+)Foxp3(+)+regulatory+T+cells+via+binding+and+re-release+of+TGF-&#946;.">Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-&#946;.</a> Immunol cell biol. , (2016).</li><li>Baron, U., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=DNA+demethylation+in+the+human+FOXP3+locus+discriminates+regulatory+T+cells+from+activated+FOXP3(+)+conventional+T+cells.">DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.</a> Eur. J. Immunol. 37, 2378-2389 (2007).</li><li>Schmidt, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+regulatory+T+cells+rapidly+suppress+T+cell+receptor-induced+Ca(2+),+NF-kappaB,+and+NFAT+signaling+in+conventional+T+cells.">Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-kappaB, and NFAT signaling in conventional T cells.</a> Sci. Signal. 4, 90 (2011).</li><li>Ohkura, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=T+cell+receptor+stimulation-induced+epigenetic+changes+and+Foxp3+expression+are+independent+and+complementary+events+required+for+Treg+cell+development.">T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.</a> Immunity. 37, 785-799 (2012).</li><li>Hill, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Retinoic+acid+enhances+Foxp3+induction+indirectly+by+relieving+inhibition+from+CD4+CD44hi+Cells.">Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.</a> Immunity. 29, 758-770 (2008).</li><li>Yang, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hydrogen+Sulfide+Promotes+Tet1-+and+Tet2-Mediated+Foxp3+Demethylation+to+Drive+Regulatory+T+Cell+Differentiation+and+Maintain+Immune+Homeostasis.">Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.</a> Immunity. 43 (2), 251-263 (2015).</li><li>Yue, X., Trifari, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Control+of+Foxp3+stability+through+modulation+of+TET+activity.">Control of Foxp3 stability through modulation of TET activity.</a> The Journal of experimental medicine. 213 (3), 377-397 (2016).</li><li>Sasidharan Nair, V., Song, M. H., Oh, K. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Vitamin+C+Facilitates+Demethylation+of+the+Foxp3+Enhancer+in+a+Tet-Dependent+Manner.">Vitamin C Facilitates Demethylation of the Foxp3 Enhancer in a Tet-Dependent Manner.</a> J Immunol. 196 (5), 2119-2131 (2016).</li><li>Geiger, T. L., Tauro, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nature+and+nurture+in+Foxp3+++regulatory+T+cell+development,+stability,+and+function.">Nature and nurture in Foxp3 + regulatory T cell development, stability, and function.</a> Hum Immunol. 73 (3), 232-239 (2012).</li><li>Gu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=TGF-&#946;-induced+CD4+Foxp3++T+cells+attenuate+acute+graft-versus-host+disease+by+suppressing+expansion+and+killing+of+effector+CD8++cells.">TGF-&#946;-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells.</a> J Immunol. 193 (7), 3388-3397 (2014).</li><li>Brusko, T. M., Hulme, M. A., Myhr, C. B., Haller, M. J., Atkinson, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessing+the+In+Vitro+Suppressive+Capacity+of+Regulatory+T+Cells.">Assessing the In Vitro Suppressive Capacity of Regulatory T Cells.</a> Immunol Invest. 36 (5-6), 607-628 (2007).</li><li>McMurchy, A. N., Levings, M. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Suppression+assays+with+human+T+regulatory+cells:+a+technical+guide.">Suppression assays with human T regulatory cells: a technical guide.</a> Eur J immunol. 42 (1), 27-34 (2012).</li><li>Mutis, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+regulatory+T+cells+control+xenogeneic+graft-versus-host+disease+induced+by+autologous+T+cells+in+RAG2-/-gammac-/-+immunodeficient+mice.">Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.</a> Clin cancer res. 12 (18), 5520-5525 (2006).</li><li>Tran, D. Q. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+suppression+assay+for+functional+assessment+of+human+regulatory+T+cells.">In vitro suppression assay for functional assessment of human regulatory T cells.</a> Meth mol biol. 979, 199-212 (2013).</li><li>Oberle, N., Eberhardt, N., Falk, C. S., Krammer, P. H., Suri-Payer, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+Suppression+of+Cytokine+Transcription+in+Human+CD4+CD25+T+Cells+by+CD4+Foxp3++Regulatory+T+Cells:+Independence+of+IL-2+Consumption,+TGF-beta,+and+Various+Inhibitors+of+TCR+Signaling.">Rapid Suppression of Cytokine Transcription in Human CD4+CD25 T Cells by CD4+Foxp3+ Regulatory T Cells: Independence of IL-2 Consumption, TGF-beta, and Various Inhibitors of TCR Signaling.</a> J. Immunol. 179, 3578-3587 (2007).</li><li>Shevach, E. M., Thornton, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=tTregs,+pTregs,+and+iTregs:+similarities+and+differences.">tTregs, pTregs, and iTregs: similarities and differences.</a> Immunol. Rev. 259, 88-102 (2014).</li></ol>

所描述的协议使人类CD4 + FOXP3 +来自人幼稚CD4 + T细胞的iTregs的鲁棒诱导。它包括我们最近描述的，使用TGF-β，全反式维甲酸和雷帕霉素的组合，对于具有优异的体外抑制功能22的iTregs的感应一个新的协议。相比其他发表的方案，另一个优点是不同iTreg种群的并联感应由不同的协议，从而使的某些iTreg诱导因子效应的直接比较，与在存在单独的IL-2活化的对照细胞沿着。所描述的...

CD4 + CD25 + FOXP3 +调节性T细胞（Treg细胞）抑制其他免疫细胞，并外周耐受的关键介质，防止自身免疫和炎症反应过度1。 Treg细胞的重要性是由人类疾病immunodysregulation多内分泌腺病肠病X连锁综合征（IPEX），其中的Treg的损失，由于在`master&#39; Treg细胞转录因子叉头框P3突变（FOXP3）例举导致严重的全身性自身免疫性疾病，致命自幼。然而，调节性T细胞作为免疫系统，因为他们也可以妨碍某些设置2抗肿瘤免疫力一把双刃剑。调节性T细胞的数量和功能的治疗操纵因此受到众多临床研究。在癌症中，调节性T细胞耗竭可能是可取的，临床的方法取得了一些成功鼓励进一步研究3。在自身免疫和炎性疾病，除了在塞弗Treg细胞的治疗效果拉尔小鼠疾病模型，继Treg细胞转移的最近最早在人的试验，以防止移植物抗 -host病（GVHD）4 - 7和评估安全性在治疗1型糖尿病8显示了非常有前途的结果。 天然存在的Tregs（nTregs）包括在保持健康9胸腺衍生tTregs和外周诱导的pTregs，具有非冗余必要功能- 11。然而，nTreg数量有限，鼓励诱导调节性T细胞（iTregs的） 在体外从幼稚T细胞前体12的补充方法。仍然稳定的iTregs的，大概是由于缺乏在FOXP3基因座13的所谓的Treg特异性去甲基化区域（TSDR）去甲基化，仍令人担忧和若干研究表明， 在诱导的Tregs 体内更稳定14。 迄今为止，FOXP3仍然是最好的M蛋白arker对于调节性T细胞，但也并非绝对特定，因为人类的常规的CD4 + CD25-T细胞中瞬时激活后15,16表达FOXP3的中间水平。虽然显著进展已经阐明FOXP3表达的调节而完成的，仍有许多关于特别是在人类细胞中FOXP3的诱导，稳定性和功能被发现。尽管差异nTregs， 在体外诱导FOXP3 + CD4 + T细胞可以作为一个模型系统以研究FOXP3诱导分子机制和作为起点到在将来开发的协议，其允许产生的iTregs的那些更类似于体内产生的Treg，这可能是适用于在将来继转移策略。 没有`金standard&#39;协议以诱导人的iTregs，和当前的协议都基于模仿Treg细胞诱导条件在体内被开发：白细胞介素-2（IL-2）和转化生长因子β（TGF-β）信号对于FOXP3诱导体内 17是至关重要的，和全反式维甲酸（ATRA） -这是在体内通过肠相关树突细胞产生的-被经常用来增强FOXP3感应在体外 18 - 21。我们已经开发出利用丁酸22中 ，最近显示，以增加鼠Treg的感应23,24一个肠道微生物衍生的短链脂肪酸的其他人Treg诱导协议。我们最近还建立用于产生具有体外优异的抑制功能的iTregs的一个新的协议，通过使用TGF-β，ATRA的组合和雷帕霉素22，后者是雷帕霉素（mTOR的）的临床批准哺乳动物靶抑制剂是已知促进人Treg扩张25,26中FOXP3维护。 该方法描述了在再现的体外代人CD4 + FOXP3 +使用一组不同的条件的iTregs，并通过流式细胞术和定量逆转录聚合酶链反应及其后续的表型的（QRT-PCR），以揭示FOXP3的表达等的Treg签名分子如的协议特定的图案如CD25，CTLA-4，EOS，以及IFN-γ和SATB1 表达 22的压制。所产生的细胞群可用于关于抑制活性官能测定或对分子研究，无论是关于一般的FOXP3调节剂或研究特定的某些化合物，如丁酸盐或雷帕霉素的效果。驾驶Treg细胞分化的分子机制进一步的了解是在自身免疫或癌症的未来治疗方法专门针对参与调节性T细胞的产生和功能分子高度相关。

<table border="0" cellpadding="0" cellspacing="0" width="1689">
	<colgroup>
		<col />
		<col />
		<col />
		<col />
	</colgroup>
	<tbody>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">All-trans retinoic acid</td>
			<td style="width:176px;">Sigma Aldrich</td>
			<td style="width:248px;">R2625-50MG&#160;&#160;</td>
			<td style="width:764px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anit-human Foxp3-APC clone 236A/E7</td>
			<td>eBioscience</td>
			<td>17-4777-42</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD25 microbeads</td>
			<td>Miltenyi Biotec</td>
			<td>130-092-983</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD25-PE</td>
			<td>Miltenyi Biotec</td>
			<td>130-091-024</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD28 antibody, LEAF Purified&#160;</td>
			<td>Biolegend</td>
			<td>302914</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD3 Antibody, LEAF Purified&#160;</td>
			<td>Biolegend</td>
			<td>317315</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">anti-human CD45RA , FITC</td>
			<td>Miltenyi Biotec</td>
			<td style="width:248px;">130-092-247</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD45RO PE clone UCHL1</td>
			<td>BD Biosciences</td>
			<td>555493</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD4-PerCP clone SK3; mIgG1</td>
			<td>BD Biosciences</td>
			<td>345770</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human CD8-eFluor 450 (clone OKT8), mIgG2a</td>
			<td>eBioscience</td>
			<td>48-0086-42&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">anti-human CTLA-4 (CD152), clone BNI3, mIgG2ak, Brilliant violet 421</td>
			<td>BD Biosciences</td>
			<td>562743</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">anti-human IFN-g FITC clone 4S.B3; mIgG1k</td>
			<td>eBioscience</td>
			<td>11-7319-81&#160;</td>
			<td style="width:764px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">Brefeldin A-containing solution: GolgiPlug</td>
			<td>BD Biosciences</td>
			<td>555029</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">cDNA synthesis kit: SuperScript VILO(Reverse transcriptase) cDNA Synthesis Kit</td>
			<td style="width:176px;">Invitrogen</td>
			<td style="width:248px;">11754-250</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">Density centrifugation medium: Ficoll-Paque</td>
			<td style="width:176px;">GE healthcare</td>
			<td style="width:248px;">17-1440-03</td>
			<td></td>
		</tr>
		<tr height="21">
			<td height="21" style="height:22px;">DMSO 99,7%</td>
			<td>Sigma Aldrich</td>
			<td>D2650-5X5ML</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">FBS, heat inactivated</td>
			<td>Invitrogen</td>
			<td>10082-147</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Fixable Viability Dye, eFluor 780&#160;&#160;</td>
			<td>eBioscience</td>
			<td>65-0865-14 or 65-0865-18&#160;</td>
			<td style="width:764px;"></td>
		</tr>
		<tr height="36">
			<td height="36" style="height:36px;">Foxp3 Staining Buffer Set</td>
			<td>eBioscience</td>
			<td>00-5523-00&#160;</td>
			<td style="width:764px;">Caution, contains Paraformaldehyde 
			Can be also bought in combined kit with antibody; 77-5774-40 Anti-Human Foxp3 Staining Set APC Clone: 236A/E7 Set&#160;</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">GlutaMAX (200 mM L-alanyl-L-glutamine)</td>
			<td>Invitrogen</td>
			<td>35050-061</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">human naive CD4 T cell isolation kit II</td>
			<td>Miltenyi Biotec</td>
			<td>130-094-131</td>
			<td></td>
		</tr>
		<tr height="20">
			<td align="left" height="20" style="height:21px;"><img alt="nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT" height="1" src="file:///C:/Users/DAVIDK~1/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png" width="2" />
			<table cellpadding="0" cellspacing="0">
				<tbody>
					<tr>
						<td height="20" style="height:21px;width:501px;">human naive CD4 T cell isolation kit II</td>
					</tr>
				</tbody>
			</table>
			</td>
			<td align="left"><img alt="nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT,nojavascript&amp;WT" height="1" src="file:///C:/Users/DAVIDK~1/AppData/Local/Temp/msohtmlclip1/01/clip_image004.png" width="1" />
			<table cellpadding="0" cellspacing="0">
				<tbody>
					<tr>
						<td height="20" style="height:21px;width:176px;">Miltenyi Biotec</td>
					</tr>
				</tbody>
			</table>
			</td>
			<td>130-094-131</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Human serum albumin 50 g/l</td>
			<td>Baxter</td>
			<td>1501057</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Ionomycin from Streptomyces conglobatus &#62;98%</td>
			<td style="width:176px;">Sigma Aldrich</td>
			<td>I9657-1MG</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">MACS LS-columns</td>
			<td>Miltenyi Biotec</td>
			<td>130-042-401</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">mouse IgG1 K Isotype Control APC Clone: P3.6.2.8.1&#160;</td>
			<td>eBioscience</td>
			<td>17-4714-42&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">mouse IgG1 K Isotype Control FITC 50 ug&#160;</td>
			<td>eBioscience</td>
			<td>11-4714-81&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">mouse IgG2a isotype control, Brilliant violet 421, clone MOPC-173</td>
			<td>BD Biosciences</td>
			<td>563464</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Pasteur pipet plastic, individually packed</td>
			<td>Sarstedt</td>
			<td>86.1172.001&#160;&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">PMA PHORBOL 12-MYRISTATE 13-ACETATE</td>
			<td>Sigma Aldrich</td>
			<td>P1585-1MG&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Rapamycin</td>
			<td>EMD (Merck)</td>
			<td>553210-100UG</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Recombinant Human IL-2, CF</td>
			<td>R&#38;D</td>
			<td>202-IL-050/CF</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;width:501px;">Recombinant Human TGF-beta 1, CF</td>
			<td>RnD</td>
			<td>240-B-010/CF</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">RNA isolation kit: RNAqueous-Micro Kit</td>
			<td style="width:176px;">Ambion</td>
			<td>AM1931&#160;&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">RPMI 1640 Medium&#160;</td>
			<td>Invitrogen</td>
			<td>72400-054&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">Sodium butyrate</td>
			<td>Sigma Aldrich</td>
			<td>B5887-250MG&#160;</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">T cell culture medium: X-Vivo 15 medium, with gentamicin+phenolred</td>
			<td>Lonza</td>
			<td>04-418Q</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">TaqMan Gene Expression Assay, FOXP3 (Best Coverage)&#160;</td>
			<td style="width:176px;">Applied Biosystems</td>
			<td style="width:248px;">4331182; assay ID: Hs01085834_m1</td>
			<td>Caution, contains Paraformaldehyde</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:21px;">TaqMan Gene Expression Assay, RPL13A (Best Coverage)</td>
			<td style="width:176px;">Applied Biosystems</td>
			<td>4351370; assay ID: Hs04194366_g1&#160;&#160;</td>
			<td>Caution, contains Paraformaldehyde</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:501px;">TaqMan Gene Expression Master mix</td>
			<td style="width:176px;">Applied Biosystems</td>
			<td style="width:248px;">4369514</td>
			<td></td>
		</tr>
	</tbody>
</table>

in vitro differentiation of human cd4+foxp3+ induced regulatory t cells (itregs) from na&#239;ve cd4+ t cells using a tgf-&#946;-containing protocol

Regulatory T cells (Tregs) are an integral part of peripheral tolerance, suppressing immune reactions against self-structures and thus preventing autoimmune diseases. Clinical approaches to adoptively transfer Tregs, or to deplete Tregs in cancer, are underway with promising first outcomes. 
Because the number of naturally occurring Tregs (nTregs) is very limited, studying certain Treg features using in vitro induced Tregs (iTregs) can be advantageous. To date, the best although not absolutely specific protein marker to delineate Tregs is the transcription factor FOXP3. Despite the importance of Tregs including non-redundant roles of peripherally induced Tregs, the protocols to generate iTregs are currently controversial, particularly for human cells. This protocol therefore describes the in vitro differentiation of human CD4+FOXP3+ iTregs from human na&#239;ve T cells using a range of Treg-inducing factors (TGF-&#946; plus IL-2 only, or their combination with retinoic acid, rapamycin or butyrate) in parallel. It also describes the phenotyping of these cells by flow cytometry and qRT-PCR. 
These protocols result in reproducible expression of FOXP3 and other Treg signature genes and enable the study of general FOXP3-regulatory mechanisms as well as protocol-specific effects to delineate the impact of certain factors. iTregs can be utilized to study various phenotypic aspects as well as molecular mechanisms of Treg induction. Detailed molecular studies are facilitated by relatively large cell numbers that can be obtained. 
A limitation for the application of iTregs is the relative instability of FOXP3 expression in these cells compared to nTregs. iTregs generated by these protocols can also be used for functional assays such as studying their suppressive function, in which iTregs induced by TGF-&#946; plus retinoic acid and rapamycin display superior suppressive activity. However, the suppressive capacity of iTregs can differ from nTregs and the use of appropriate controls is crucial.

图1示出实验装置的方案。 图2示出了用于磁性分离的幼稚的CD4 + T细胞和nTregs的代表性纯度对照染色。 ˚Figure 3A显示仪设门的流动和图3B显示代表FOXP3和CD25流式细胞仪染色的培养6日表示iTreg或控制的条件下。 在体外刺激后，大多数细胞上调CD25，它是在雷帕霉素?...

Watch this Scientific Journal Video about In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells iTregs from NaÃƒÂ¯ve CD4+ T Cells Using a TGF-ÃŽÂ²-containing Protocol at JoVE.com

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells iTregs from NaÃƒÆ’Ã†'Ãƒâ€šÃ‚Â¯ve CD4+ T Cells Using a TGF-ÃƒÆ’Ã…Â½Ãƒâ€šÃ‚Â²-containing Protocol

本协议描述从幼稚CD4 + T细胞在体外可重复产生和人为调节性T细胞（iTregs的）的表型。不同的协议FOXP3诱导允许与各自的协议获取特定表型iTreg的研究。

在从幼稚的CD4 + T细胞的人CD4 + FOXP3 +诱导调节性T细胞（iTregs的）使用含有TGF-β-协议的体外分化

Regulatory T cells (Tregs) are an integral part of peripheral tolerance, suppressing immune reactions against self-structures and thus preventing ...

Research

JoVE Journal

Immunology and Infection

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Na&#239;ve CD4+ T Cells Using a TGF-&#946;-containing Protocol

Retroviral Transduction of T-cell Receptors in Mouse T-cells

T细胞受体在小鼠T细胞的逆转录病毒转导

T-cell receptors (TCRs) play a central role in the immune system. TCRs on T-cell surfaces can specifically recognize peptide antigens presented by antigen ...

科研

免疫与感染

Generation of Induced Regulatory T Cells from Primary Human Na&iuml;ve and Memory T Cells

Generation of Induced Regulatory T Cells from Primary Human NaÃƒÆ’Ã‚Â¯ve and Memory T Cells

从初级人类的幼稚和记忆T细胞的诱导调节性T细胞的生成

The development and maintenance of immunosuppressive CD4+ regulatory T cells (Tregs) contribute to the peripheral tolerance needed to remain in ...

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

定向分化诱导性多潜能干细胞向T淋巴细胞

Adoptive cell transfer (ACT) of antigen-specific CD8+  cytotoxic T lymphocytes (CTLs) is a promising treatment for a variety of  malignancies 1. CTLs can  ...

piggyBac Transposon System Modification of Primary Human T Cells

piggyBac Transposon System Modification of Primary Human T Cells

piggyBac转座子初级人类T细胞系统改造

The piggyBac transposon system is naturally active, originally derived from the cabbage looper moth1,2. This non-viral system is plasmid based, most ...

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

新工具展开调节性T细胞的HIV-1感染的个体

CD4+ Regulatory T cells (Tregs) are potent immune modulators and serve an important function in human immune homeostasis. Depletion of Tregs has led to ...

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

腺病毒转导朴素的CD4 T细胞调节性T细胞分化研究

Regulatory T cells (Tregs) are essential to provide immune tolerance to self as well as to certain foreign antigens. Tregs can be generated from naive CD4 ...

Isolation and Th17 Differentiation of Na&iuml;ve CD4 T Lymphocytes

Isolation and Th17 Differentiation of NaÃƒÆ’Ã‚Â¯ve CD4 T Lymphocytes

隔离和幼稚的CD4 T细胞的Th17细胞分化

Th17 cells are a distinct subset of T cells that have been found to produce interleukin 17 (IL-17), and differ in function from the other T cell subsets ...

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

评估的HIV-1感染的CD4的先天传感<sup&gt; +</sup&gt;性T细胞浆细胞样树突细胞使用<em&gt;体外</em&gt;共培养体系。

HIV-1 innate sensing requires direct contact of infected CD4+ T cells with plasmacytoid dendritic cells (pDCs). In order to study this process, the ...

Derivation of T Cells In Vitro from Mouse Embryonic Stem Cells

Derivation of T Cells In Vitro from Mouse Embryonic Stem Cells

对T细胞推导<em&gt;在体外</em&gt;从小鼠胚胎干细胞

The OP9/OP9-DL1 co-culture system has become a well-established method for deriving differentiated blood cell types from embryonic and hematopoietic ...

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

从外周血人类同种异体抗原特异性T细胞的生成

The study of human T lymphocyte biology often involves examination of responses to activating ligands. T cells recognize and respond to processed peptide ...